DrugCite

Arixtra and Muscle Haemorrhage

This page shows results related to Arixtra and Muscle Haemorrhage from the FDA Adverse Event Reporting System (AERS).

Click here to learn about all Arixtra adverse events.

Adverse Event
Safe Use Tools
Learn More
Comments

Arixtra and Muscle Haemorrhage

Age

>60 Years
167
50-59 Years
25
40-49 Years
10
30-39 Years
2

Gender

Male: 29%
Female: 67%
Gender Unknown: 4%

Outcome

What were the most common outcomes of those reporting Muscle Haemorrhage?

Hospitalization
181
Life Threatening
51
Death
40
Other
38
Disability
8

Reporter

Who most commonly reported Muscle Haemorrhage?

Consumer
108
Physician
91
Other
14
Pharmacist
7

Therapy

Of those reporting Muscle Haemorrhage, why were they taking Arixtra?

Thrombosis Prophylaxis
39
Deep Vein Thrombosis
36
Pulmonary Embolism
26
Drug Use For Unknown Indication
25
Phlebitis
10

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.*

YESNOUNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?
Probability of an Adverse Event
Doubtful
Possible
Probable
Definite

*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Arixtra, view the complete Arixtra adverse event report.

Scientific Publications on Muscle Haemorrhage

Powered by Google

Comments

Share your experience with Arixtra and Muscle Haemorrhage.